Drug application
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE)
Drugs@FDA ANDA 202894 · GLENMARK SPECLT
Key facts
| Drug name | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE |
|---|---|
| Active ingredients | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE |
| Application type | ANDA |
| Application number | 202894 |
| Company | GLENMARK SPECLT |
| Dosage forms | CREAM, TOPICAL |
| Strength | EQ 0.05% BASE;1% |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Oct 30, 2015 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.